These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 31340569)
1. Microglial Phenotyping in Neurodegenerative Disease Brains: Identification of Reactive Microglia with an Antibody to Variant of CD105/Endoglin. Walker DG; Lue LF; Beach TG; Tooyama I Cells; 2019 Jul; 8(7):. PubMed ID: 31340569 [TBL] [Abstract][Full Text] [Related]
2. Patterns of Expression of Purinergic Receptor P2RY12, a Putative Marker for Non-Activated Microglia, in Aged and Alzheimer's Disease Brains. Walker DG; Tang TM; Mendsaikhan A; Tooyama I; Serrano GE; Sue LI; Beach TG; Lue LF Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31968618 [TBL] [Abstract][Full Text] [Related]
3. Increased expression of toll-like receptor 3, an anti-viral signaling molecule, and related genes in Alzheimer's disease brains. Walker DG; Tang TM; Lue LF Exp Neurol; 2018 Nov; 309():91-106. PubMed ID: 30076830 [TBL] [Abstract][Full Text] [Related]
4. Immunohistochemistry using antibodies to alpha-interferon and its induced protein, MxA, in Alzheimer's and Parkinson's disease brain tissues. Yamada T; Horisberger MA; Kawaguchi N; Moroo I; Toyoda T Neurosci Lett; 1994 Nov; 181(1-2):61-4. PubMed ID: 7898772 [TBL] [Abstract][Full Text] [Related]
5. Neuroinflammation in Alzheimer's disease and Parkinson's disease: are microglia pathogenic in either disorder? Rogers J; Mastroeni D; Leonard B; Joyce J; Grover A Int Rev Neurobiol; 2007; 82():235-46. PubMed ID: 17678964 [TBL] [Abstract][Full Text] [Related]
6. Phenotypic profile of alternative activation marker CD163 is different in Alzheimer's and Parkinson's disease. Pey P; Pearce RK; Kalaitzakis ME; Griffin WS; Gentleman SM Acta Neuropathol Commun; 2014 Feb; 2():21. PubMed ID: 24528486 [TBL] [Abstract][Full Text] [Related]
7. Modulation of Inflammatory Mediators and Microglial Activation Through Physical Exercise in Alzheimer's and Parkinson's Diseases. de Almeida EJR; Ibrahim HJ; Chitolina Schetinger MR; de Andrade CM; Cardoso AM Neurochem Res; 2022 Nov; 47(11):3221-3240. PubMed ID: 35962936 [TBL] [Abstract][Full Text] [Related]
8. Prolyl oligopeptidase colocalizes with α-synuclein, β-amyloid, tau protein and astroglia in the post-mortem brain samples with Parkinson's and Alzheimer's diseases. Hannula MJ; Myöhänen TT; Tenorio-Laranga J; Männistö PT; Garcia-Horsman JA Neuroscience; 2013 Jul; 242():140-50. PubMed ID: 23562579 [TBL] [Abstract][Full Text] [Related]
9. Activated microglial cells and complement factors are unrelated to cortical Lewy bodies. Rozemuller AJ; Eikelenboom P; Theeuwes JW; Jansen Steur EN; de Vos RA Acta Neuropathol; 2000 Dec; 100(6):701-8. PubMed ID: 11078223 [TBL] [Abstract][Full Text] [Related]
10. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease. Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770 [TBL] [Abstract][Full Text] [Related]
11. Inflammation: major denominator of obesity, Type 2 diabetes and Alzheimer's disease-like pathology? Kacířová M; Zmeškalová A; Kořínková L; Železná B; Kuneš J; Maletínská L Clin Sci (Lond); 2020 Mar; 134(5):547-570. PubMed ID: 32167154 [TBL] [Abstract][Full Text] [Related]
12. Investigations with cultured human microglia on pathogenic mechanisms of Alzheimer's disease and other neurodegenerative diseases. Walker DG; Lue LF J Neurosci Res; 2005 Aug; 81(3):412-25. PubMed ID: 15957156 [TBL] [Abstract][Full Text] [Related]
13. Decreased expression of CD200 and CD200 receptor in Alzheimer's disease: a potential mechanism leading to chronic inflammation. Walker DG; Dalsing-Hernandez JE; Campbell NA; Lue LF Exp Neurol; 2009 Jan; 215(1):5-19. PubMed ID: 18938162 [TBL] [Abstract][Full Text] [Related]
14. TMEM119 marks a subset of microglia in the human brain. Satoh J; Kino Y; Asahina N; Takitani M; Miyoshi J; Ishida T; Saito Y Neuropathology; 2016 Feb; 36(1):39-49. PubMed ID: 26250788 [TBL] [Abstract][Full Text] [Related]
15. Immune phenotypes of microglia in human neurodegenerative disease: challenges to detecting microglial polarization in human brains. Walker DG; Lue LF Alzheimers Res Ther; 2015 Aug; 7(1):56. PubMed ID: 26286145 [TBL] [Abstract][Full Text] [Related]
16. Amyloid beta plaque-associated proteins C1q and SAP enhance the Abeta1-42 peptide-induced cytokine secretion by adult human microglia in vitro. Veerhuis R; Van Breemen MJ; Hoozemans JM; Morbin M; Ouladhadj J; Tagliavini F; Eikelenboom P Acta Neuropathol; 2003 Feb; 105(2):135-44. PubMed ID: 12536224 [TBL] [Abstract][Full Text] [Related]
18. Changes in CD200 and intercellular adhesion molecule-1 (ICAM-1) levels in brains of Lewy body disorder cases are associated with amounts of Alzheimer's pathology not α-synuclein pathology. Walker DG; Lue LF; Tang TM; Adler CH; Caviness JN; Sabbagh MN; Serrano GE; Sue LI; Beach TG Neurobiol Aging; 2017 Jun; 54():175-186. PubMed ID: 28390825 [TBL] [Abstract][Full Text] [Related]
19. Role of cytokines in inflammatory process in Parkinson's disease. Sawada M; Imamura K; Nagatsu T J Neural Transm Suppl; 2006; (70):373-81. PubMed ID: 17017556 [TBL] [Abstract][Full Text] [Related]
20. Increased expression of the urokinase plasminogen-activator receptor in amyloid beta peptide-treated human brain microglia and in AD brains. Walker DG; Lue LF; Beach TG Brain Res; 2002 Feb; 926(1-2):69-79. PubMed ID: 11814408 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]